Labshake search
Citations for R&D Systems :
1 - 50 of 3271 citations for Pituitary Tumor Transforming 1 PTTG1 Antibody since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Molecular Biology 2021Quote: ... and 1 ng/mL transforming growth factor β (TGF-β; R&D Systems), as described (43) ...
-
bioRxiv - Immunology 2020Quote: ... transforming growth factor (TGF)-β1 (R&D Systems, Bio-Techne ...
-
bioRxiv - Bioengineering 2021Quote: ... dickkopf-related protein-1 (Dkk-1) and transforming growth factor beta 1 (TGF-β1) were obtained from R&D systems (Minneapolis, MN) and performed on conditioned media from hMSCs grown on GelMA and OCM-GelMA microcarriers in RWV bioreactors.
-
bioRxiv - Cancer Biology 2019Quote: ... and transforming growth factor (TGF)-β1 (R&D system, MN, USA) were checked using ELISA kits ...
-
bioRxiv - Cell Biology 2020Quote: ... to RAW264.7 or 2 ng/mL transforming growth factor β-1(240-B/CF, R&D System, USA) to THP-1 for 24-36 hours ...
-
bioRxiv - Biophysics 2023Quote: ... 10 ng/mL recombinant human transforming growth factor beta 1 (TGF-β1 from R&D System, Minnesota, USA). For 3D cultures ...
-
Tuning trophoblast invasion in a gelatin hydrogel via soluble cues from the maternal-fetal interfacebioRxiv - Bioengineering 2020Quote: ... Recombinant human transforming growth factor β1 (TGFβ1; R&D Systems, 240-B) and recombinant human epidermal growth factor (EGF ...
-
bioRxiv - Synthetic Biology 2020Quote: ... 10 ng/mL transforming growth factor beta 3 (TGF-β3, R&D Systems) and 100nM dexamethasone12,27 to make implantable cartilage constructs11 ...
-
bioRxiv - Physiology 2021Quote: Plasma transforming growth factor beta (TGF-β; DY240, R&D Systems, Minneapolis, MN), and IL-6 (ELC-IL6-1 ...
-
bioRxiv - Microbiology 2021Quote: ... 10ng/ml interleukin 4 (IL-4) and 10ng/ml transforming growth factor beta 1 (TGFβ1) (R&D systems, Minneapolis, MN), and used between days 7-9 of differentiation.
-
bioRxiv - Immunology 2020Quote: ... 4 ng/ml human transforming growth factor α (TGFα; R&D Systems, MN, USA) as a positive control ...
-
bioRxiv - Systems Biology 2021Quote: ... 10 ng/ml transforming growth factor beta one (TGFβ1, recombinant human, R&D systems) 25 μg/mL l-ascorbic acid 2-phosphate (Sigma Aldrich) ...
-
bioRxiv - Bioengineering 2023Quote: ... and transforming growth factor–β3 (10 ng/ml; 243-B3-200; R&D Systems). On day 1 of culture ...
-
bioRxiv - Bioengineering 2023Quote: ... Fibroblasts were treated with or without recombinant human transforming growth factor beta 1 (TGF-β1) protein (240-B, R&D Systems) at 1.25 ng/mL ...
-
bioRxiv - Bioengineering 2020Quote: ... supplemented with 1 ng/mL transforming growth factor beta-1 (TGF-β1) and 5 ng/mL fibroblast growth factor-2 (FGF-2) (both from R&D Systems) at 37°C and 5% CO2 in a humidified incubator (Thermo Scientific Heraeus ...
-
bioRxiv - Molecular Biology 2023Quote: ... Cells were treated with media containing recombinant mouse transforming growth factor-beta 1 (rmTGFβ1) at 5ng/mL (R&D systems, 7666-MB) or normal media ...
-
bioRxiv - Cancer Biology 2020Quote: ... IHC score for tumor SDF-1 staining (Clone 79018 R&D Systems, IHC staining details are available in Appendix Supplementary Methods ...
-
bioRxiv - Genomics 2019Quote: ... and 10 ng/ml recombinant human transforming growth factor beta 3 (rhTGF-b3) (R&D Systems). Pellets were formed at the end of passage 6 ...
-
bioRxiv - Pharmacology and Toxicology 2023Quote: ... stimulation with transforming growth factor β (TGF-β, 240-B, R&D Systems, Minneapolis, MN, USA), dissolved in 0.1% (weight/volume [w/v] ...
-
bioRxiv - Molecular Biology 2019Quote: ... cells were serum starved overnight and then incubated with 10 ng/ml recombinant human transforming growth factor-beta 1 (TGF-β1) (R&D Systems, Minneapolis, MN) for indicated times.
-
bioRxiv - Bioengineering 2020Quote: ... Tumor cells were resuspended in 1x PBS and mixed with methylcellulose (1:1 ratio) (R&D Systems). 8- to 10-week old naïve C57BL/6 mice were anesthetized with isoflurane and placed in a stereotactic frame ...
-
bioRxiv - Bioengineering 2020Quote: ... 2) transforming growth factor beta-2 (TGF-β2; 2.5 ng/ml; R&D Systems, Minneapolis, MN, USA), 3 ...
-
bioRxiv - Physiology 2021Quote: ... supplemented with bovine pituitary extract and epidermal growth factor (EGF) (R&D Systems, Minneapolis, MN, USA), 10−10 molL-1 cholera toxin (Calbiochem ...
-
bioRxiv - Cancer Biology 2019Quote: ... lymph node tissue sections derived from mice bearing pancreatic tumors were incubated overnight at RT with the following primary antibodies: NKp46 (R&D systems AF2225, used at 1:25), Ki67 (Abcam ab15580 ...
-
bioRxiv - Developmental Biology 2021Quote: ... 10 ng/ml human transforming growth factor-β3 (TGFβ3; cat. num. 243-B3-010/CF; R&D Systems, Minneapolis, MN), 1 µM Wnt-C59 ...
-
bioRxiv - Molecular Biology 2023Quote: The recombinant human transforming growth factor beta (TGFβ) protein and recombinant human TSP2 protein were obtained from R&D Systems. The SMAD3 Inhibitor SIS3 was procured from Cayman Chemical Company ...
-
bioRxiv - Molecular Biology 2021Quote: Recombinant human transforming growth factor-β (TGF-β) and fibroblast growth factor-2 FGF-2 were purchased from R&D Systems. BTZ ...
-
bioRxiv - Pharmacology and Toxicology 2020Quote: ... tumor necrosis factor alpha (TNFα; R&D systems, 210-TA), Lactate dehydrogenase (LDH ...
-
bioRxiv - Cell Biology 2019Quote: ... Tumor necrosis factor-alpha (TNFα) were obtained from R&D Systems. Cathepsin Inhibitor 1 (S2847) ...
-
bioRxiv - Physiology 2020Quote: ... tumor necrosis factor α (TNF-α; R&D Systems, Minneapolis, MN), interleukin 6 (IL-6 ...
-
bioRxiv - Developmental Biology 2020Quote: Embryonic immortalised mouse epicardium-derived cells (mEPDC) were treated with 2.0 µg/ml human recombinant transforming growth factor (TGF)-β (R&D Systems; 240-B) for 30 hrs to induce EMT ...
-
bioRxiv - Cell Biology 2019Quote: ... and expanded chondroprogenitor cells were re-suspended at 2.5 × 105 cells / mL in chondrogenic medium supplemented with 10 ng/ml human transforming growth factor beta 3 (TGF-β3; R&D Systems, Minneapolis, MN). Chondrogenic pellets were cultured at 37°C for 28 days ...
-
bioRxiv - Biophysics 2020Quote: ... 10ng/mL recombinant tumor necrosis factor-α (TNF-α, R&D Systems), and 100ng/mL of recombinant interferon-γ (IFN-γ ...
-
bioRxiv - Immunology 2021Quote: ... and tumor necrosis factor (TNF)α (R&D Systems®, LXSAHM-04). Briefly ...
-
bioRxiv - Cell Biology 2023Quote: ... or tumor necrosis factor alpha (TNFα, 20 ng/mL, R&D systems) were used as positive controls.
-
Cholesterol deprivation induces TGFβ signaling to promote basal differentiation in pancreatic cancerbioRxiv - Cancer Biology 2019Quote: The amount of TGFβ secreted by mouse pancreatic tumor cells was quantified by using the Mouse TGFβ 1 DuoSet ELISA (#DY1679-05, R&D systems), complemented with Sample Activation Kit 1 (#DY010 ...
-
bioRxiv - Systems Biology 2022Quote: ... mouse tumor necrosis factor alpha (TNF-α; R&D Systems, aa 80-235), mouse interleukin 1 beta (IL-1β ...
-
bioRxiv - Neuroscience 2019Quote: ... 30 ng/mL tumor necrosis factor alpha (R&D Systems; 210-TA-020) and 400 ng/mL C1q (MyBioSource ...
-
bioRxiv - Bioengineering 2023Quote: ... Supernatant was probed for tumor necrosis factor alpha (TNFα, R&D Systems, mta006), IL10 (Invitrogen ...
-
bioRxiv - Neuroscience 2022Quote: ... and 50ng/ml tumor necrosis factor α (TNFα, R&D Systems #410-MT-025).
-
bioRxiv - Cancer Biology 2022Quote: ... CXCL5 ELISA from tumor lysates was performed using commercial kit (R&D Systems, MX000) by following their instructions manual.
-
bioRxiv - Immunology 2021Quote: ... tumor necrosis factor (TNF)-α (25 ng/mL; R&D Systems Cat# 210-TA), and polyinosinic:polycytidylic acid (20 ng/mL ...
-
bioRxiv - Biophysics 2023Quote: ... A “type-1” like cytokine cocktail consisted of 10 ng/ml of recombinant mouse tumor necrosis factor-α (TNF-α, R&D Systems, Minneapolis, MN), 5 ng/ml of recombinant mouse interleukin-1β (IL-1β ...
-
bioRxiv - Cell Biology 2019Quote: ... Q-VD-OPh and Tumor Necrosis Factor-alpha (TNFα) were obtained from R&D Systems. Ionomycin was purchased from Calbiochem ...
-
bioRxiv - Cell Biology 2023Quote: Apoptosis of tumor cells was determined with an Annexin-FITC staining kit (R&D Systems) as per the manufacturer’s instructions and analyzed by flow cytometry ...
-
bioRxiv - Developmental Biology 2024Quote: ... Anti-Netrin-1 antibody 1:500 (R&D Systems AF1109) in 1% BSA + 0.1% PBST was incubated at 4C overnight ...
-
bioRxiv - Cell Biology 2022Quote: ... but supplemented with 30ng/μl tumor necrosis factor alpha (TNFα; R&D systems, #210-TA-020) for 7d ...
-
bioRxiv - Immunology 2023Quote: ... Antibodies were anti-IL-1b antibody (BAF401, R&D Systems, 1:1,000). DRAQ5 was from Thermo Fisher Scientific ...
-
bioRxiv - Biochemistry 2019Quote: ... anti-HAI-1 antibody (R&D Systems), anti-WT-1 antibody (Santa Cruz Biotechnology Inc) ...
-
bioRxiv - Physiology 2023Quote: ... anti-PECAM-1 antibody (goat, 1:400, R&D Systems, USA), anti-VEGFR2 (rabbit ...